|
|
||||||||
From the Ocular Surface Center and Ocular Surface Research and Education Foundation, Miami, Florida.
| Abstract |
|---|
|
|
|---|
METHODS. One eye of 17 patients with ATD was randomly selected for this noncomparative case series. Twelve patients also had noninflamed meibomian gland dysfunction (MGD). Sequential images were digitized and analyzed on computer. Data were further compared in 9 of the 17 cases before and after punctal occlusion (PO). Outcome measures included speed and pattern of lipid spread and resultant lipid layer thickness in the superior, central, and inferior cornea. Intensity and red/green/blue (RGB) color spectra of the tear interference image were compared before and after PO.
RESULTS. After lid blinking, it took a longer time (2.2 ± 1.1 second) to reach a stable lipid film in all eyes with ATD compared with normal subjects (P < 0.0001). Because of this retarded spread, the thickest lipid film was located at the inferior cornea adjacent to the lid margin, with a gradient spreading toward the superior cornea (P = 0.01). As a result, the lipid film was thinner than normal on the superior cornea in 10 of 17 (59%) ATD eyes. Fifteen of 17 eyes (88%) showed vertical streaking, rather than a normal horizontal propagation pattern on the superior cornea. Such a lipid-deficient state and uneven distribution did not correlate with the presence or absence of MGD. The lipid spread time was shortened (P = 0.008), the distribution of the lipid film was more even, and the thickness approached normal in all nine eyes after PO.
CONCLUSIONS. In this study, kinetic analysis of tear interference images provided evidence that retardation of lipid spread is, but MGD is not, the main reason for the increased thickness of precorneal lipid film in the inferior cornea of eyes with ATD. As a result, lipid film is deficient in the superior cornea and unevenly distributed, further destabilizing the tear film. The fact that PO significantly improves lipid spread, evenness, and thickness suggests that the performance of lipid film is also dictated by the amount of aqueous tear fluid. These findings provide new insight into the interaction between the lipid film and the aqueous tear fluid.
One requirement for maintaining a stable tear film is that a sufficient amount of meibum lipids must spread rapidly into a thin film with appropriate thickness and even distribution. Such a lipid film helps stabilize the tear film by lowering the air-fluid surface tension and preventing aqueous tear evaporation.3 Tear interferometry is a noninvasive method used by many to visualize and evaluate the tear lipid layer.4 5 6 7 8 9 10 11 12 13 14 15 16 17
It is well known that the formation of a lipid film requires lid-blinking, which is a kinetic event. Therefore, we believe that it is important to retrieve tear interference images timed with the onset of blinking, and that a random, non-time-controlled single image of tear interference taken before may not represent what exactly happens during the interblink interval. That is why we developed kinetic analysis and discovered dramatic differences between eyes of patients with lipid tear deficiency (LTD) dry eye and eyes of normal subjects.18 Our results indicate that the normal lipid film spreads rapidly in a horizontally propagating wave pattern, whereas that of LTD slowly spreads in a vertically streaking pattern (P < 0.0001,
2 test). Also, the normal lipid film spreads and produces a stable image within 0.36 ± 0.22 second, whereas that of LTD produces a stable image in 3.54 ± 1.86 seconds (P = 0.0003, Mann-Whitney test). Subsequent images of the normal lipid film show that it remains evenly distributed, with an average thickness of 79.1 ± 13.0 nm, whereas those of LTD show that the film remains unstable and uneven with an average thickness of 53.8 ± 20.0 nm (P = 0.02 Mann-Whitney test).
Several studies have indicated that the precorneal tear lipid layer in dry eye shows different appearance from that of normal eyes.19 20 21 22 23 Danjo and Hamano8 reported that the thickness increases with the intensity of vital staining in aqueous tear deficient (ATD) dry eye with Sjögren syndrome. Yokoi et al.9 reported that the thickness of the tear lipid film increases with severity of ATD. One explanation for such a thicker lipid film in eyes with ATD may be the increased production of meibum lipids. Yokoi et al.24 reported that the meibum lipid level measured by meibometry is increased in the lid margin reservoir of women with ATD, speculating that this is caused by the compression of a thicker lipid film left on the lid margin.
In this study, we used kinetic analysis of interference images to provide strong evidence supporting the hypothesis that the thicker lipid found in eyes with ATD is not due to increased meibum production but results from retardation of lipid spread, which leads to uneven distribution of lipid film and deficient lipid film on the superior cornea. The significance of this finding is further discussed.
| Methods |
|---|
|
|
|---|
|
All patients had not undergone punctal occlusion (PO), were not contact lens wearers, and did not have blepharospasm or abnormal blinking at the time of enrollment. After the baseline evaluation, patients were treated with topical medications, such as nonpreserved artificial tear eye drops hourly and preservative-free methylprednisolone eye drops three times a day for a course of 3 weeks. Nine of 17 patients remained symptomatic and subsequently underwent punctal occlusion with plug or cauterization in the lower punctum of each eye. Repeated tear interference images were taken 1 day to 52 weeks after PO.
Instrument Setup
In an examination room set at the same light intensity (350 lux), humidity (45.2%54.0%), and temperature (21.022.7°C), we used the same instrument setup as previously reported.18 In short, an ophthalmoscope (DR-1; Kowa, Inc., Nagoya, Japan) was set at a magnification of 12x, which allowed observation of an area of the cornea 8 mm in diameter. The video output was linked with a frame grabber (FlashBus MV Lite; Integral Technologies, Indianapolis, IN) and digitized as uncompressed audio-video interleaved (AVI) format using image-management software (ImagePro 4.1; Media Cybernetics, Silver Spring, MD). The frame rate was set at 5.18 frames per second (the sequential frames spanned 0.193-second intervals) and recording was performed for 29 seconds in one session, which generated 150 frames (131-megabyte video file). In a preliminary study, we had compared the data randomly chosen among three separate sets of blinks and noted that there were no significant differences among them (P = 0.4, Wilcoxons matched-pairs signed rank test). Therefore, we present herein data obtained from one representative blink, which started with a complete eyelid blink and its interblink time (IBT). These sequential video images were then extracted as uncompressed tag image file format (TIFF) file, which could be made into a thumbnail composite and subjected to subsequent image analysis.
Kinetic Analysis of Interference Images
Lipid Spread Time and Pattern of Spread.
The time interval starting from time 0 to the time of the frame that first showed a stable interference image was defined as lipid spread time, as we have reported previously.18 The first stable image was determined by playing the images frame by frame on a liquid crystal display (LCD) screen, to see whether there was any noticeable movement between frames. When there was no noticeable movement, we defined it as the first stable image. This measurement was conducted by two nonmasked observers, and the longer time of the two was chosen in the event of a disagreement. Throughout their analyses there was complete agreement between the two observers 65% of the time. Among the 35% in which there was a discrepancy, the difference was limited to two frames in 80% of the cases and to three frames in 20%. If the image did not achieve a stable pattern throughout the entire IBT, the entire IBT was used to calculate the spread time.
The spread pattern was recorded as horizontally propagating, vertically streaking, or mixed when judged by three masked observers, as previously reported.18
Distribution of the Lipid Film Thickness.
Using the first stable frame taken from the sequential images, we analyzed four spots along the vertical meridian in an 8-mm diameter image: spot A, located at 2 mm above the center; spot B at the center; spot C, 2 mm below the center; and spot D, 4 mm below the center (Fig. 1A) . Each spot consisted of 14 pixels, from which an average of image intensity was obtained by the imaging software (Fig. 1A , for spots A and D; depicted in the horizontal axis). Using the look-up simulated color chart (LUT) showing the reflectance of thin film interference generated by a white light source32 (Fig. 1B) and the red/green/blue (RGB) spectra of that spot by the image software (Fig. 1C 1D 1E 1F) , which helped determine the interference order, we translated the average intensity value into the thin film thickness (see legend of Fig. 1 for an example). The differences among the thicknesses measured at spots A, B, C, and D were used to quantify the distribution, or evenness, of the spread of lipid film. To demonstrate the changes in the distribution of thickness before and after PO, we also measured the RGB color spectra in the superior and inferior corneas, and compared these spectra before and after PO.
|
2 test and that of the interval scales by Mann-Whitney test. The comparison of categorical scales between nine patients with ATD before and after PO was performed by
2 test and that of interval scales by Wilcoxon matched-pairs signed rank test. To analyze the distribution of the lipid thickness, we applied the Kruskal-Wallis test. The statistical tests were performed on computer (Instat 3.0; GraphPad Software, Inc., San Diego, CA). P < 0.05 was considered statistically significant. | Results |
|---|
|
|
|---|
|
|
|
|
|
|
Group B consisted of cases 11 to 13, in which the lipid film was thicker on the superior cornea than that in group A, giving rise to a color of bright gray to white, indicating the average thickness of 76.7 ± 20.8 nm. Such a thickness was within the normal range (79.1 ± 13.0 nm).18 However, a vertical streaking pattern, which was not noted in normal eyes,18 was clearly observed in this region (Fig. 3A) . Group C included cases 14 to 17, in which the lipid film on the superior cornea became more colorful, yielding an average thickness of 133 ± 78.5 nm, thicker than normal. Even if the lipid thickness was increased in group C, a vertical streaking pattern was still visible on the superior cornea in three of four cases (cases 14, 16, and 17). After PO, besides the aforementioned changes of thickness and distribution, we also noted that the vertical streaking pattern on the superior cornea was changed to a horizontally propagating pattern, similar to that in normal eyes,18 in three of nine cases (cases 3, 15, and 16).
| Discussion |
|---|
|
|
|---|
The first evidence supporting our assertion was derived from the measurement of the lipid spread time, defined by the interval before a stable image is first reached. Unlike a rather short lipid spread time of 0.36 ± 0.22 second reported in normal eyes,18 all 17 eyes with ATD had a significantly slower spread time of 2.17 ± 1.09 seconds (P < 0.0001). Due to the retarded lipid spread, a lipid film with a gradient of decreasing thickness was generated from the inferior cornea to the superior cornea, and an uneven distribution resulted. This was demonstrated qualitatively by interference images taken at the time when a stable image was reached (Fig. 3A) , as well as quantitatively by measuring the thickness at the four different spots (Table 2 , Fig. 1 ). The uneven distribution of the lipid film also resulted in nonuniformity of the entire lipid distribution, which was best illustrated quantitatively by the distribution of RGB spectra in superior and inferior corneas (Fig. 4 , middle and bottom left).
Based on the frame taken when a stable image was first reached, we noted heterogeneity in the lipid film thickness among the three groups in these 17 patients with ATD (Fig. 3A , Table 2 ). Group A had a lipid film thinner than normal (i.e., dark gray color on the superior cornea). This pattern was also observed by Danjo and Hamano8 and Mathers et al.10 Nevertheless, groups B and C had a lipid film on the superior cornea similar to or thicker than normal. Unlike the normal lipid film, which spreads in a horizontal propagating wave pattern,18 nearly all except two eyes (cases 15 and 16) showed a vertical streaking pattern on the superior cornea where the lipid film was deficient. Danjo and Hamano8 noted a similar vertical pattern (though not described as such) in eyes of 49% of their patients with Sjögren syndrome. We have previously ascribed such a vertical streaking pattern as one of the major characteristics of the lipid film of LTD eyes.18 Therefore, we speculate that uneven distribution of the lipid film may further destabilize the tear film, and that the vertical streaking, which reflects mechanical movement of eyelid upward excursion, may traumatize the ocular surface in patients with ATD. If this interpretation were correct, we believe that future ATD therapy should also include the restoration of the lipid film to achieve effective results.
The aforementioned gradient of lipid film distribution and the heterogeneity of lipid film thickness did not correlate with the presence or absence of MGD (Table 3) , supporting that the thicker lipid film noted in eyes of patients with ATD is not caused by increasing meibum production. Although there was a tendency suggesting the increasing severity of ATD from group A to (combined) groups B and C with respect to positive staining and absence of reflex tearing, this trend did not reach a statistical significance. In group A, the patient in case 1 had Sjögren syndrome and the one in case 6 had positive superficial punctate keratopathy on the inferior cornea, where a thick lipid was also present, with black granules (Fig. 3A) . The latter finding resembled the "oil droplets" described by Danjo and Hamano.8 Future studies with a larger sample size will help resolve whether kinetic analysis of tear interference images may also help better correlate the severity of ATD.
The second line of evidence supporting that a thicker lipid in ATD is caused by retardation of lipid spread is the comparison of thickness data before and after PO. As summarized in Table 4 , the lipid spread time was significantly shortened in nine patients with ATD after PO. As a result, the pattern of spread changed from vertical streaking to horizontal wave patterns, the distribution became much more uniform and even, and the overall thickness approached normal (Fig. 3B) . It should also be noted that such a dramatic change could occur as early as 1 day and last for as long as 52 weeks, so long as the volume of the aqueous tear fluid was increased by PO. Because the same improvement of tear interference by PO was observed in patients with ATD, with or without MGD, and in both group A and groups B and C, we further believe that the most important element that affects the lipid film spread time and distribution in patients with ATD is the amount of the aqueous tear fluid.
Because PO could make such a dramatic improvement in the quality of the lipid film, even in patients with severe lipid tear deficiency (group A), we also concur with the findings of Yokoi et al.24 that meibum lipids are actually not absent in patients with ATD and could have been stagnated at the lid margin. If this interpretation is accurate, we also speculate that increasing the amount of aqueous tear fluid is important for effective lipid spread in patients with ATD. An intriguing finding was that in groups B and C, PO also resulted in the return to a much thicker lipid film, rather close to normal (Fig. 3B) . This finding prompts us to speculate that heterogeneity in the severity of ATD or in the production of various lipid species, especially polar versus nonpolar lipids, may influence lipid spread. Future studies are needed to delineate the exact mechanism by which lipid spread is retarded when the aqueous tear fluid is deficient in ATD.
| Acknowledgements |
|---|
| Footnotes |
|---|
Presented in part at the Annual Meeting of Association of Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2002.
Supported by a grant from Bio-Lipid, Inc. and in part by a grant from Ocular Surface Research & Education Foundation.
Submitted for publication August 13, 2002; revised October 11, 2002; accepted November 14, 2002.
Disclosure: E. Goto (P); S.C.G. Tseng, Bio-Lipid, Inc. (F, P)
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Scheffer C. G. Tseng, Ocular Surface Center, 8780 SW 92 Street, Suite 203, Miami, FL; stseng{at}ocularsurface.com.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Dogru, K. Ishida, Y. Matsumoto, E. Goto, M. Ishioka, T. Kojima, T. Goto, M. Saeki, and K. Tsubota Strip Meniscometry: A New and Simple Method of Tear Meniscus Evaluation Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1895 - 1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Montes-Mico, J. L. Alio, and W. N. Charman Dynamic Changes in the Tear Film in Dry Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1615 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T.-S. Liu, M. A. Di Pascuale, J. Sawai, Y.-Y. Gao, and S. C. G. Tseng Tear Film Dynamics in Floppy Eyelid Syndrome Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1188 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kojima, R. Ishida, M. Dogru, E. Goto, Y. Takano, Y. Matsumoto, M. Kaido, Y. Ohashi, and K. Tsubota A New Noninvasive Tear Stability Analysis System for the Assessment of Dry Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1369 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Goto, M. Dogru, T. Kojima, and K. Tsubota Computer-Synthesis of an Interference Color Chart of Human Tear Lipid Layer, by a Colorimetric Approach Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4693 - 4697. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |